Discontinuation of teriflunomide and dimethyl fumarate in a large Italian multicentre population: a 24-month real-world experience.

Mariangela Sciandra, Giuseppe Salemi, Borriello, Cottone, Emanuele D’Amico, Valentino, Antonio Gallo, Zanghì, Bossio, Giuseppe Salemi, Maria Buccafusca, Paola Valentino, Mario Zappia, Pozzilli, Luigi M.E. Grimaldi, Patti, Gioacchino Tedeschi, Graziella Callari

Risultato della ricerca: Article

5 Citazioni (Scopus)

Abstract

A retrospective study on prospectively collected data was performed in nine tertiary MS centers, in Italy. The 24-month discontinuation rate in the two cohorts was the primary study outcome. We also assessed the time to discontinuation and reasons of therapy withdrawn. Discontinuation of TRF and DMF was defined as a gap of treatment ≥ 60 days.
Lingua originaleEnglish
pagine (da-a)411-416
Numero di pagine6
RivistaJournal of Neurology
Volume266
Stato di pubblicazionePublished - 2018

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology

Cita questo

Sciandra, M., Salemi, G., Borriello, Cottone, D’Amico, E., Valentino, Gallo, A., Zanghì, Bossio, Salemi, G., Buccafusca, M., Valentino, P., Zappia, M., Pozzilli, Grimaldi, L. M. E., Patti, Tedeschi, G., & Callari, G. (2018). Discontinuation of teriflunomide and dimethyl fumarate in a large Italian multicentre population: a 24-month real-world experience. Journal of Neurology, 266, 411-416.